These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 19486034)

  • 1. A prostaglandin D2 receptor antagonist modifies experimental asthma in sheep.
    Shichijo M; Arimura A; Hirano Y; Yasui K; Suzuki N; Deguchi M; Abraham WM
    Clin Exp Allergy; 2009 Sep; 39(9):1404-14. PubMed ID: 19486034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
    Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
    Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.
    Yasui K; Asanuma F; Hirano Y; Shichijo M; Deguchi M; Arimura A
    Eur J Pharmacol; 2008 Jan; 578(2-3):286-91. PubMed ID: 17927976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effect of PGD2 via prostanoid DP receptor on TNF-alpha-induced production of MCP-1 and IL-8 in human monocytic THP-1 cells.
    Hirano Y; Shichijo M; Deguchi M; Nagira M; Suzuki N; Nishitani Y; Hattori M; Arimura A
    Eur J Pharmacol; 2007 Mar; 560(1):81-8. PubMed ID: 17307163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation.
    Stebbins KJ; Broadhead AR; Correa LD; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Eur J Pharmacol; 2010 Jul; 638(1-3):142-9. PubMed ID: 20447387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
    Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
    Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
    Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
    J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.
    Hirano Y; Shichijo M; Ikeda M; Kitaura M; Tsuchida J; Asanuma F; Yanagimoto T; Furue Y; Imura K; Yasui K; Arimura A
    Eur J Pharmacol; 2011 Sep; 666(1-3):233-41. PubMed ID: 21596028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the potent and selective DP1 receptor antagonist, asapiprant (S-555739), in animal models of allergic rhinitis and allergic asthma.
    Takahashi G; Asanuma F; Suzuki N; Hattori M; Sakamoto S; Kugimiya A; Tomita Y; Kuwajima G; Abraham WM; Deguchi M; Arimura A; Shichijo M
    Eur J Pharmacol; 2015 Oct; 765():15-23. PubMed ID: 26277322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin D2 mediates neuronal protection via the DP1 receptor.
    Liang X; Wu L; Hand T; Andreasson K
    J Neurochem; 2005 Feb; 92(3):477-86. PubMed ID: 15659218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
    Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
    J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor.
    Shiraishi Y; Asano K; Nakajima T; Oguma T; Suzuki Y; Shiomi T; Sayama K; Niimi K; Wakaki M; Kagyo J; Ikeda E; Hirai H; Yamaguchi K; Ishizaka A
    J Pharmacol Exp Ther; 2005 Mar; 312(3):954-60. PubMed ID: 15528449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).
    Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y
    Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonist.
    Gervais FG; Sawyer N; Stocco R; Hamel M; Krawczyk C; Sillaots S; Denis D; Wong E; Wang Z; Gallant M; Abraham WM; Slipetz D; Crackower MA; O'Neill GP
    Mol Pharmacol; 2011 Jan; 79(1):69-76. PubMed ID: 20943773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the PGD
    Kupczyk M; Kuna P
    Drugs; 2017 Aug; 77(12):1281-1294. PubMed ID: 28612233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
    Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
    J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
    Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretory leukocyte protease inhibitor prevents allergen-induced pulmonary responses in animal models of asthma.
    Wright CD; Havill AM; Middleton SC; Kashem MA; Lee PA; Dripps DJ; O'Riordan TG; Bevilacqua MP; Abraham WM
    J Pharmacol Exp Ther; 1999 May; 289(2):1007-14. PubMed ID: 10215681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.